EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

COVID-19 host genetics and ABO blood group susceptibility

David Ellinghaus iD

Cambridge Prisms: Precision Medicine · 2023

DOI: 10.1017/pcm.2022.12 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cambridge Prisms: Precision Medicine, 2023. Verfasst von David Ellinghaus. Beteiligte Einrichtung: Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Twenty-five susceptibility loci for SARS-CoV-2 infection and/or COVID-19 disease severity have been identified in the human genome by genome-wide association studies, and the most frequently replicated genetic findings for susceptibility are genetic variants at the ABO gene locus on chromosome 9q34.2, which is supported by the association between ABO blood group distribution and COVID-19. The ABO blood group effect appears to influence a variety of disease conditions and pathophysiological mechanisms associated with COVID-19. Transmission models for SARS-CoV-2 combined with observational public health and genome-wide data from patients and controls, as well as receptor binding experiments in cell lines and human samples, indicate that there may be a reduction or slowing of infection events by up to 60% in certain ABO blood group constellations of index and contact person in the early phase of a SARS-CoV-2 outbreak. The strength of the ABO blood group effect on reducing infection rates further depends on the distribution of the ABO blood groups in the respective population and the proportion of blood group O in that population. To understand in detail the effect of ABO blood groups on COVID-19, further studies are needed in relation to different demographic characteristics, but also in relation to recent data on reinfection with new viral variants and in the context of the human microbiome.

Schlagwörter

Stichwörter der Autor:innen

ABO blood group susceptibilityABO geneABO-compatibility-dependence modelCOVID-19 host geneticsCOVID-19 susceptibility lociSARS-CoV-2 transmission models

Autor:innen und Institutionen

  • Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.

ORCID-Profile: David Ellinghaus

Zitieren

APA

Ellinghaus, D. (2023). COVID-19 host genetics and ABO blood group susceptibility. Cambridge Prisms: Precision Medicine. https://doi.org/10.1017/pcm.2022.12

Vancouver

Ellinghaus D. COVID-19 host genetics and ABO blood group susceptibility. Cambridge Prisms: Precision Medicine. 2023. doi:10.1017/pcm.2022.12

BibTeX
@article{Ellinghaus2023,
  author = {Ellinghaus, David},
  title = {COVID-19 host genetics and ABO blood group susceptibility},
  journal = {Cambridge Prisms: Precision Medicine},
  year = {2023},
  doi = {10.1017/pcm.2022.12}
}
Kostenlos starten →